// App-Quantinova.ai

OP0024 : USE OF HYDROXYCHLOROQUINE AND RISK OF HEART FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS

Researchers

Presenter

  • A. Sorour

Principal Investigators

  • Y. Shahin

  • C. S. Crowson

  • R. Kurmann

  • S. Achenbach

  • R. Mankad

  • E. Myasoedova

Medical Centers

  • Mayo Clinic, Division of Cardiovascular Diseases, Rochester, United States of America

  • Mayo Clinic, Biomedical Statistics and Informatics, Jacksonville, United States of America

  • Mayo Clinic, Rheumatology, Rochester, MN, United States of America

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Congestive heart failure

  • Inflammatory Arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved